Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancer.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Javier Cortes Christelle Levy Carlo Putzu Xavier Pivot Fabio Puglisi |
| Publication date | August 8, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |